An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients

NCT03619187 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Heart Transplantation, Elevated Resting Heart Rate

Interventions

DRUG: Ivabradine

Sponsor

Amgen